Frequently Asked Questions
The market is segmented based on Global Artificial Intelligence (AI)-based Clinical Trials Market, By Clinical Trial Phase (Phase-I, Phase-II, Phase-III), Application (Oncology, Cardiovascular Diseases, Neurological Diseases or Conditions, Infectious Diseases, Others), End-use (Pharmaceutical Companies, Academia, Others) – Industry Trends and Forecast to 2029
.
The Global Artificial Intelligence Ai Based Clinical Trials Market size was valued at USD 1.30 USD Billion in 2021.
The Global Artificial Intelligence Ai Based Clinical Trials Market is projected to grow at a CAGR of 19.9% during the forecast period of 2022 to 2029.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
